MCT/Butyrate with SunButyrate 15.6 fl oz by Douglas Laboratories
MCT/Butyrate with SunButyrate 15.6 fl oz is a cognitive health supplement designed by Douglas Laboratories.* It is based on two unique ingredients: MCT and Butyrate, which together promote ketone production in your brain.* Ketones, on the other hand, are energy-producing molecules that aid cognitive function.*
Who Should Consider MCT/Butyrate with SunButyrate 15.6 fl oz?
MCT/Butyrate with SunButyrate 15.6 fl oz by Douglas Laboratories may be for you if:
- you experience age-related cognitive decline*
- want to suppress your appetite*
- seek overall cognitive support*
MCT/Butyrate with SunButyrate 15.6 fl oz by Douglas Laboratories—Effects
MCT/Butyrate with SunButyrate 15.6 fl oz may have the following effects:
- enhance neuroprotection*
- promote oxidative defense*
- stimulate energy production in your brain*
- enhance cerebral blood flow*
Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Book a FREE product consultation to learn more about MCT/Butyrate with SunButyrate 15.6 fl oz by Douglas Laboratories.
Recommendation:
Douglas Laboratories suggests as a dietary supplement for adults, taking 1 tablespoon, 1-3 times daily with meals, or as directed by your health professional.
Serving Size: 1 Tablespoon
Servings per Container: 30
Amount per Serving:
Calories 130
Total Fat 14 g
Saturated Fat 10 g
Medium-Chain Triglycerides Providing 8 g caprylic acid (C8) 8.6 g
SunButyrate Butyrate Triglyceride Providing 965 mg butyric acid 5 g
Other Ingredients: Natural vanilla flavor, lemon oil, mixed tocopherols (from sunflower), rosemary extract
Warning: If you are pregnant or nursing, or if you are taking prescription medications, consult your health professional before using this supplement. Keep out of children.
Storage: Store in a cool, dry place. Use only if safety seal is intact.
Contents may not fill package in order to accommodate required labeling. Please rely on stated quantity.
Douglas Laboratories logo, text, graphics, and photo images are the property of Société des Produits Nestlé S.A. and are used with permission. Copyright © 2021.
*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
References:
- Canani, R. B., Costanzo, M. D., Leone, L., Pedata, M., Meli, R., & Calignano, A. (2011). Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World Journal of Gastroenterology, 17(12), 1519–1528. https://doi.org/10.3748/wjg.v17.i12.1519
Banasiewicz, T., Krokowicz, Ł., Stojcev, Z., Kaczmarek, B. F., Kaczmarek, E., Maik, J., & Marciniak, R. (2013). Microencapsulated sodium butyrate reduces the frequency of abdominal pain in patients with irritable bowel syndrome. Colorectal Disease, 15(2), 204–209. https://doi.org/10.1111/codi.12019 - Pryde, S. E., Duncan, S. H., Hold, G. L., Stewart, C. S., & Flint, H. J. (2002). The microbiology of butyrate formation in the human colon. FEMS Microbiology Letters, 217(2), 133–139. https://doi.org/10.1016/S0378-1097(02)01182-0
- Hiippala, K., Jouhten, H., Ronkainen, A., Huuskonen, L., de Vos, W. M., & Satokari, R. (2018). The potential of gut commensals in reinforcing intestinal barrier function and alleviating inflammation. Nutrients, 10(8), 988. https://doi.org/10.3390/nu10080988
- Thibault, R., Blachier, F., Darcy-Vrillon, B., De Coppet, P., Bourreille, A., & Segain, J. P. (2010). Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: A transport deficiency. Inflammatory Bowel Diseases, 16(4), 684–695. https://doi.org/10.1002/ibd.21108
- St-Pierre, V., Courchesne-Loyer, A., Vandenberghe, C., Hennebelle, M., Castellano, C. A., Fortier, M., & Cunnane, S. C. (2017). Butyrate is linked to cognitive performance via ketosis and the gut microbiome. Journal of Functional Foods, 32, 170–175. https://doi.org/10.1016/j.jff.2017.02.007
- Bach Knudsen, K. E., Laerke, H. N., Hedemann, M. S., Nielsen, T. S., Ingerslev, A. K., Gundelund Nielsen, D. S., Theil, P. K., & Lauridsen, C. (2018). Impact of diet-modulated butyrate production on intestinal barrier function and inflammation. Nutrients, 10(10), 1499. https://doi.org/10.3390/nu10101499
- Cushing, K., Alvarado, D. M., & Ciorba, M. A. (2015). Butyrate and mucosal inflammation: New scientific evidence supports clinical application. Clinical and Translational Gastroenterology, 6, e108. https://doi.org/10.1038/ctg.2015.29
- Courchesne-Loyer, A., Croteau, E., Castellano, C. A., St-Pierre, V., Hennebelle, M., Cunnane, S. C., & Fortier, M. (2013). Ketone body metabolism in the brain: From metabolic imaging to therapeutic implications. Nutrition, 29(4), 635–640. https://doi.org/10.1016/j.nut.2012.11.004
- Page, K. A., Chan, O., Arora, J., Belfort-DeAguiar, R., Dzuira, J., Roehmholdt, B., Cline, G., Naik, S., Sinha, R., Constable, R. T., & Sherwin, R. S. (2009). Effects of fructose vs glucose on brain and appetite responses to food cues and decisions. Diabetes, 58(5), 1237–1244. https://doi.org/10.2337/db08-1628
- Yadav, H., Lee, J. H., Lloyd, J., Walter, P., & Rane, S. G. (2013). Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. Journal of Biological Chemistry, 288(35), 25088–25097. https://doi.org/10.1074/jbc.M113.452516
- Li, H., Gao, Z., Zhang, J., Ye, X., Xu, A., Ye, J., & Jia, W. (2016). Sodium butyrate stimulates glucagon-like peptide-1 secretion in streptozotocin-induced diabetic rats. Diabetes, 61(4), 797–806. https://doi.org/10.2337/db11-1026
- McGarry, J. D., & Foster, D. W. (1980). Regulation of hepatic fatty acid oxidation and ketone body production. Annual Review of Biochemistry, 49(1), 395–420. https://doi.org/10.1146/annurev.bi.49.070180.002143